Other indications

International registry on the use of the CytoSorb-Adsorber in ICU patients (NCT02312024)

Schein M, Bahr V, Rissner F, Jakob M, Schumacher U, Brunkhorst FM
Infection. 2015 Aug;43Suppl 1:1-73. Abstract No. 125

This article gives an overview on the objectives and methods of the currently implemented international...

This article gives an overview on the objectives and methods of the currently implemented international CytoSorb registry.

Feasibility study of cytokine removal by hemoadsorption in brain-dead humans

Kellum JA, Venkataraman R, Powner D, Elder M, Hergenroeder G, Carter M
Crit Care Med. 2008 Jan;36(1):268-72

Through numerousmechanisms, brain death is associatedwith a massive release of proinflammatory cytokines, detectable both in...

Through numerousmechanisms, brain death is associatedwith a massive release of proinflammatory cytokines, detectable both in blood and transplantable organs. This increased inflammatory response has been associated withpoor allograft function before and after transplantation. Therefore, this in vivo study examines the feasibility of hemoadsorption (using CytoSorb) to remove cytokines in brain-dead humans (n=8).